Immunotherapy and biological response modifiers are essential techniques in surgical oncology aimed at modulating the immune system to enhance the efficacy of c...
Immunotherapy and biological response modifiers are essential techniques in surgical oncology aimed at modulating the immune system to enhance the efficacy of cancer treatment.
Immunotherapy involves harnessing the power of the immune system to recognize and attack cancer cells. This can be achieved through various mechanisms, including immune checkpoint blockade, adoptive cell therapy, and oncolytic viruses. By stimulating the immune system to recognize and eliminate cancer cells, immunotherapy offers hope for patients with advanced cancers who may not respond well to traditional treatments.
Biological response modifiers are drugs that directly influence the immune system to either activate or suppress immune responses. These drugs can be used to enhance the immune system's ability to recognize and attack cancer cells, or they can be used to block immune checkpoints that interfere with immune cell function. Examples of biological response modifiers include immune checkpoint inhibitors, oncolytic viruses, and cytokine therapy.
The combination of immunotherapy and biological response modifiers can lead to synergistic effects, resulting in improved antitumor immune responses and enhanced treatment outcomes. By combining these approaches, healthcare providers aim to overcome the limitations of individual treatments and improve patient outcomes for patients with cancer